Clinical factors predicting a rapid response to short-acting beta2 agonists in mild and moderate asthma exacerbations.

Background: The need for establishing criteria that facilitate decision-making has lead to search for factors that could predict prognosis and response to treatment for asthma exacerbations.

Objective: To assess which clinical factors are associated with a rapid response to short-acting beta2 agonists during asthma exacerbations.

Patients And Methods: Two hundred and twenty consecutive adults with mild to moderate asthma crisis were included.